Piper Jaffray & Co. initiates coverage on Pharmaceutical Product Development (Nasdaq: PPDI) with a Buy. Price target $34.

This article: 186 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE